Pendrea Bio, Inc.
PrivateLast Round
Series A
Oct 1, 2020
Total Funding Raised
$4.5M
Company Overview
Pendrea Bio, Inc. operates in Healthcare & Life Sciences and is based in Boalsburg, Pennsylvania. Its latest recorded funding round was a Seed round in October 2020.
Pendrea Bio, Inc. is a biotechnology company that develops nanotechnology platforms, including calcium-phosphate NanoJackets for RNA therapeutics and photo-immuno nano therapy for oncology applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pendrea Bio, Inc. Comparables
Compare Pendrea Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cello Therapeutics | 79% | |
| TransCode Therapeutics, Inc. | 79% | |
| Duo Oncology | 79% |
For institutional investors. Book with your work email.
Pendrea Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 1, 2020 | ||||
| Seed | Oct 1, 2020 | ||||
| Grant | Oct 5, 2015 |
For institutional investors. Book with your work email.
Pendrea Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2020
$20M round completed.
For institutional investors. Book with your work email.
Pendrea Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pendrea Bio, Inc.'s valuation, stock price, and market status.
Is Pendrea Bio, Inc. a public or private company?
Pendrea Bio, Inc. is a private company.
What is the current stock price of Pendrea Bio, Inc.?
Pendrea Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Pendrea Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pendrea Bio, Inc. worth (valuation)?
Valuation information for Pendrea Bio, Inc. is not publicly available.
Can I buy Pendrea Bio, Inc. stock?
Pendrea Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pendrea Bio, Inc.'s last funding round?
Pendrea Bio, Inc.'s most recent funding round was Series A on October 1, 2020.
Who are the main investors in Pendrea Bio, Inc.?
Key investors in Pendrea Bio, Inc. include National Cancer Institute.
Will Pendrea Bio, Inc. IPO soon?
No public IPO plans have been announced for Pendrea Bio, Inc..
How can I track Pendrea Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Pendrea Bio, Inc.'s shares on secondary markets.